InsidersTradesSigma
Follow the Lineage, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was disclosed on 10 August 2026 (Acquisition). Among the most active insiders: Fleming Abigail S. All data is accessible without an account.
74
Insider Decl.
n/a
Thresholds
€11m
18 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lineage, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
44Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,753 of 29,057 companies
19.6
score / 100
Value24
Quality15
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-2.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
Declarations74 total
20,000 shares@ US$41.33190.038% mcap45.1% of flowCommon StockSEC:0001645808-26-000002:0
Canonical exit: 5 Nov 2026 (T+90)
4,490 sharesCommon StockSEC:0001684665-26-000005:0
4,490 sharesCommon StockSEC:0001628280-26-042562:0
205 shares@ US$35.550.0004% mcap32.9% of flowCommon StockSEC:0001820887-26-000006:0
13,118 shares0Common StockSEC:0001490473-26-000004:0
1,220 shares0Common StockSEC:0002094217-26-000004:0
12,203 shares0Common StockSEC:0001820887-26-000004:0
68,334 shares0Common StockSEC:0001748303-26-000004:0
20,745 shares0Common StockSEC:0002019216-26-000004:0
2,137 shares@ US$32.7633.2% of flowCommon StockSEC:0001490473-26-000004:1
1,516 shares@ US$32.76100.0% of flowCommon StockSEC:0002094217-26-000004:1
276 shares@ US$32.7629.1% of flowCommon StockSEC:0001820887-26-000004:1
8,422 shares@ US$32.76100.0% of flowCommon StockSEC:0001748303-26-000004:1
676 shares@ US$32.76100.0% of flowCommon StockSEC:0002018508-26-000004:0
13,300 shares@ US$37.496213.1% of flowCommon StockSEC:0002021239-26-000004:0
Canonical exit: 10 Jun 2026 (T+90)
11,222 shares@ US$39.05429.3% of flowCommon StockSEC:0002021239-26-000002:0
Canonical exit: 7 Jun 2026 (T+90)
616 shares0Common StockSEC:0002094217-26-000002:0
3,603 shares0Common StockSEC:0002019216-26-000002:0
4,258 shares0Common StockSEC:0002018599-26-000002:0
3,767 shares0Common StockSEC:0002018544-26-000002:0
5,405 shares0Common StockSEC:0002018532-26-000002:0
3,735 shares0Common StockSEC:0002018508-26-000002:0
1,049 shares0Common StockSEC:0001820887-26-000002:0
13,756 shares0Common StockSEC:0001748303-26-000002:0
3,603 shares0Common StockSEC:0001490473-26-000002:0
25 of 74 declarations
Acerca de Lineage, Inc.
Lineage, Inc. es una empresa que cotiza en NASDAQ y se especializa en el desarrollo de soluciones innovadoras para la industria biotecnológica. Se enfoca en la investigación y el desarrollo de productos que mejoran la salud y el bienestar.